XML 42 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Corrections to Previously Issued Consolidated Financial Statements (Details) - USD ($)
2 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2017
Dec. 31, 2016
Sep. 30, 2017
Sep. 30, 2016
Jul. 20, 2015
Consolidated Balance Sheets            
Due to related party   $ 4,229,320   $ 4,113,000    
Total Liabilities   4,400,247   4,147,914    
Additional paid-in capital   13,805,936   13,788,574    
Accumulated deficit   (15,776,598)   (15,395,384)    
Total equity (deficit) $ 633,357 (1,756,915)   (1,393,063) $ (6,379,118) $ 897,001
Consolidated Statements of Operations and Comprehensive Loss            
Selling, general and administrative expenses   289,731 $ 185,188 707,142 599,303  
Research and development expenses   45,701 25,198 3,151,162 10,000,000  
Net loss from operations   (352,794) (210,386) (3,996,342) (10,997,295)  
Net Loss (315,602) $ (381,214) $ (210,337) $ (4,071,983) $ (11,007,799)  
Basic and diluted loss per share   $ (0.00) $ (0.00) $ (0.02) $ (0.06)  
Consolidated Statements of Cash Flow            
Net loss from continuing operations $ (315,602) $ (381,214) $ (210,337) $ (4,071,983) $ (11,007,799)  
Issuance of common stock for compensation     1,295,324  
(Decrease) increase in due to related party   $ 116,320   $ 2,353,000 6,477,483  
Restatement Adjustment [Member]            
Consolidated Balance Sheets            
Due to related party         6,500,000  
Total Liabilities         6,556,470  
Additional paid-in capital         4,733,461  
Accumulated deficit         (11,323,401)  
Total equity (deficit)         (6,379,118)  
Consolidated Statements of Operations and Comprehensive Loss            
Selling, general and administrative expenses         997,263  
Research and development expenses         10,000,000  
Net loss from operations         (10,997,295)  
Loss from continuing operations before income taxes         (11,006,963)  
Net Loss         $ (11,007,799)  
Basic and diluted loss per share         $ (0.06)  
Consolidated Statements of Cash Flow            
Net loss from continuing operations         $ (11,007,799)  
Issuance of common stock for compensation         (1,295,324)  
(Decrease) increase in due to related party         6,477,483  
Scenario, Previously Reported [Member]            
Consolidated Balance Sheets            
Due to related party          
Total Liabilities         56,470  
Additional paid-in capital         4,733,401  
Accumulated deficit         (4,823,401)  
Total equity (deficit)         120,882  
Consolidated Statements of Operations and Comprehensive Loss            
Selling, general and administrative expenses         4,497,263  
Research and development expenses          
Net loss from operations         (4,497,295)  
Loss from continuing operations before income taxes         (4,506,963)  
Net Loss         $ (4,507,799)  
Basic and diluted loss per share         $ 0.00  
Consolidated Statements of Cash Flow            
Net loss from continuing operations         $ (4,507,799)  
Issuance of common stock for compensation         (1,295,324)  
(Decrease) increase in due to related party         (22,517)  
Adjustments One [Member]            
Consolidated Balance Sheets            
Due to related party          
Total Liabilities          
Additional paid-in capital         60  
Accumulated deficit          
Total equity (deficit)          
Consolidated Statements of Operations and Comprehensive Loss            
Selling, general and administrative expenses         60  
Research and development expenses          
Net loss from operations         (60)  
Loss from continuing operations before income taxes         (60)  
Net Loss         $ (60)  
Basic and diluted loss per share         $ 0.00  
Consolidated Statements of Cash Flow            
Net loss from continuing operations         $ (60)  
Issuance of common stock for compensation         60  
(Decrease) increase in due to related party          
Adjustments [Member]            
Consolidated Balance Sheets            
Due to related party         6,500,000  
Total Liabilities         6,500,000  
Additional paid-in capital          
Accumulated deficit         (6,500,000)  
Total equity (deficit)         (6,500,000)  
Consolidated Statements of Operations and Comprehensive Loss            
Selling, general and administrative expenses         (3,500,060)  
Research and development expenses         10,000,000  
Net loss from operations         (6,499,940)  
Loss from continuing operations before income taxes         (6,499,940)  
Net Loss         $ (6,499,940)  
Basic and diluted loss per share         $ (0.06)  
Consolidated Statements of Cash Flow            
Net loss from continuing operations         $ (6,499,940)  
Issuance of common stock for compensation         (60)  
(Decrease) increase in due to related party         $ 6,500,000